PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10585592-0	2000	Synergistic cytotoxicity of iodine-131-anti-CD20 monoclonal antibodies and chemotherapy for treatment of B-cell lymphomas.	Iodine-131	28-38	keratin 20	Homo sapiens	44-48	
10585592-1	2000	Preliminary clinical trials suggest that iodine-131 ((131)I)-labeled anti-CD20 monoclonal antibodies (MAbs) are effective single agents for the treatment of relapsed non-Hodgkin"s B-cell lymphomas.	Iodine-131	41-51	keratin 20	Homo sapiens	74-78	
10585592-10	2000	Thus, combination regimens containing (131)I-labeled anti-CD20 antibodies and nucleoside analogs or topoisomerase inhibitors appear particularly attractive for future clinical trials.	Iodine-131	38-44	keratin 20	Homo sapiens	58-62